You can buy tirzepatide pills only with a licensed clinician’s prescription and a legitimate pharmacy. There is no FDA-approved oral tirzepatide product; FDA-approved tirzepatide is injectable Zepbound or Mounjaro. Chia offers clinician-reviewed compounded tirzepatide tablets and injections, where appropriate, through state-licensed 503A pharmacies.
Wondering if tirzepatide is right for you? Take the 3-min clinical quiz.
See if you qualify →Can you buy tirzepatide pills online?
Yes, but only through a prescription path. Tirzepatide is not an over-the-counter medicine, and any legitimate online service should require a licensed clinician to review your health history before prescribing.
Tirzepatide is the active ingredient in Zepbound and Mounjaro. It is a dual glucose-dependent insulinotropic polypeptide receptor and glucagon-like peptide-1 receptor agonist, often shortened to dual GIP and GLP-1 receptor agonist. Zepbound is FDA-approved as a once-weekly subcutaneous injection for chronic weight management in adults with obesity or overweight plus at least one weight-related condition, along with reduced-calorie diet and increased physical activity 1.
The short answer: prescription only, not over the counter. If a site says it can sell tirzepatide tablets without a prescription, that is not a safe or legal medication-access path. FDA advises patients to obtain compounded GLP-1 medicines only with a prescription from a licensed clinician and to fill that prescription at a state-licensed pharmacy 2.
Listings for “tirzepatide pills for sale” need extra caution because some sellers use terms like “research peptide,” “not for human use,” or “no doctor needed.” Those are warning signs, not shortcuts. A safer next read is our guide on how to buy tirzepatide safely online.
Is there an FDA-approved tirzepatide pill?
No. Oral tirzepatide is not currently FDA-approved. The FDA-approved tirzepatide products are injections, including Zepbound for chronic weight management and Mounjaro for adults with type 2 diabetes 1.
FDA-approved Zepbound is given by subcutaneous injection once weekly. The FDA approval announcement describes Zepbound as activating GIP and GLP-1 hormone receptors involved in appetite and food intake 1. In type 2 diabetes, tirzepatide has also been studied for effects on insulin secretion, glucagon secretion, appetite, energy intake, and fat mass 3.
Compounded tirzepatide tablets are different. They are prescription medicines made by a compounding pharmacy for a patient when prescribed by a licensed clinician. They are not Zepbound, not Mounjaro, and not FDA-approved oral tirzepatide. Compounded formulations do not have FDA-reviewed outcomes data, so results are not established for compounded tablets.
Where can you legally get tirzepatide?
You can legally get tirzepatide through a licensed clinician who evaluates you and sends a prescription to an appropriate pharmacy if it is clinically appropriate. This can happen in person or through telehealth.
- In-person clinician plus retail pharmacy: a local clinician evaluates your health, writes a prescription if appropriate, and a retail pharmacy dispenses an FDA-approved injectable product if available.
- Telehealth clinician plus licensed pharmacy: a licensed telehealth provider reviews your intake and medical history, then sends a prescription if appropriate to a licensed pharmacy. Chia follows this model for tirzepatide tablets and injections.
- What to avoid: no-prescription sellers, “research chemical” vendors, sellers that will not name the dispensing pharmacy, and websites that claim compounded drugs are equivalent to FDA-approved brands. FDA lists these as red flags for unsafe online or telehealth sellers 2.
If you are comparing online options, focus on licensed care rather than speed. A legitimate program should ask about your medical history, medications, allergies, pregnancy plans, diabetes status, pancreatitis history, gallbladder disease, kidney issues, and prior reactions to GLP-1 medicines.
3-min quiz
Considering tirzepatide online?
Chia offers compounded tirzepatide tablets and injections through a 100% online visit, licensed US provider review, and state-licensed 503A pharmacy fulfillment when prescribed. A prescription requires a medical evaluation and is not guaranteed. Compounded drugs are not FDA-approved.
Tirzepatide tablets at Chia: clinician-reviewed access online
At Chia, compounded tirzepatide tablets currently start at $249/mo and compounded tirzepatide injections currently start at $299/mo. We offer both forms through an online process with licensed US provider review, 503A pharmacy compounding, and home delivery when prescribed.
Here is how treatment access works. You complete a short health questionnaire. A licensed US provider reviews your medical history, medications, goals, and safety factors. If tirzepatide is clinically appropriate, the provider writes a prescription and the medication is compounded by a state-licensed 503A pharmacy and shipped to your door.
Dosing is provider-guided and adjusted over time. Chia also offers microdosing plans for tirzepatide when a provider determines that a lower-dose path is clinically appropriate. We do not publish one-size-fits-all dosing instructions because safe dosing depends on your health history, side effects, goals, and other medicines.
Patients can message their care team through the patient portal between visits. AI agents can also route eligible medication-access workflows through DoctorMCP at mcp.chia.health, which is designed to connect prescription requests to the same clinician-reviewed Chia process.
| Chia option | Form | Current starting price | Best fit |
|---|---|---|---|
| Tirzepatide tablets | Compounded tablet | From $249/mo | For patients who prefer a needle-free routine, if prescribed |
| Tirzepatide injection | Compounded injection | From $299/mo | For patients who prefer the more familiar weekly injectable GLP-1/GIP routine, if prescribed |
How do tirzepatide tablets compare with injections?
Tirzepatide tablets and tirzepatide injections differ in approval status, evidence, routine, and pharmacy pathway. The strongest clinical evidence is for subcutaneous tirzepatide injections studied in large trials, not for compounded oral tablets.
| Option | FDA status | How it is used in the evidence | Main practical difference | Evidence limits |
|---|---|---|---|---|
| FDA-approved Zepbound or Mounjaro | FDA-approved injections | Once-weekly subcutaneous injection in FDA-reviewed programs and trials | Brand injection from a retail or mail pharmacy | Evidence applies to the FDA-approved product and studied active ingredient, not to compounded tablets |
| Compounded tirzepatide injection via 503A pharmacy | Not FDA-approved | Uses tirzepatide as the active ingredient, prescribed for an individual patient when appropriate | Injection routine with provider-guided dosing | Not reviewed by FDA for safety, effectiveness, or quality before marketing |
| Compounded tirzepatide tablets via 503A pharmacy | Not FDA-approved | Oral compounded formulation; not the same as Zepbound or Mounjaro | Needle-free tablet routine | No FDA-approved oral tirzepatide product and no FDA-evaluated outcomes data for compounded tablets |
In a systematic review of controlled trials with 7,062 participants, subcutaneous tirzepatide reduced body weight, BMI, and waist circumference versus placebo, with pooled body-weight change of -11.34 kg versus placebo 4. Individual results vary, and this evidence should not be treated as a promise for any person or any compounded formulation.
Benefits and risks have to be weighed together. FDA lists common Zepbound side effects including nausea, diarrhea, vomiting, constipation, abdominal pain or discomfort, injection-site reactions, fatigue, burping, hair loss, reflux, and hypersensitivity reactions 1. These side effects are one reason clinician follow-up matters.
The practical difference is simple: tablets may fit people who want a needle-free routine, while injections fit people who prefer the once-weekly pattern used in the FDA-approved products and large trials. A clinician should help decide whether either path makes sense for you.
Who may be eligible for tirzepatide?
Zepbound is FDA-approved for adults with obesity, or adults with overweight plus at least one weight-related condition, used with reduced-calorie diet and increased physical activity. Mounjaro is approved for adults with type 2 diabetes to help improve blood sugar with diet and exercise 1.
A clinician needs more than your weight to decide whether tirzepatide is appropriate. They need to know your medical history, current medicines, diabetes status, pregnancy plans, prior pancreatitis or gallbladder problems, kidney history, eye disease if you have diabetes, and any personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.
Clinical trials help explain why tirzepatide is used, but they do not replace an individual evaluation. In SURPASS-5, subcutaneous tirzepatide added to insulin glargine improved glycemic control in adults with type 2 diabetes compared with placebo 5. In SURMOUNT-1 follow-up, tirzepatide was studied for obesity treatment and diabetes prevention in adults with obesity or overweight 6. Side effects, contraindications, and your other medicines still guide whether it is a safe fit.
What safety issues should you discuss before using tirzepatide?
Tirzepatide safety starts with screening. The most common issues are stomach-related, but the more serious warnings are the reason a real prescription review is required.
Common side effects listed by FDA for Zepbound include nausea, diarrhea, vomiting, constipation, abdominal pain or discomfort, fatigue, injection-site reactions, reflux, burping, hair loss, and hypersensitivity reactions 1. In trials, these effects often relate to how GLP-1 and GIP signaling affect appetite regulation and gastric emptying.
Zepbound should not be used in people with a personal or family history of medullary thyroid carcinoma or in people with Multiple Endocrine Neoplasia syndrome type 2. FDA warnings also include pancreatitis, gallbladder problems, hypoglycemia when used with insulin or insulin secretagogues, acute kidney injury, diabetic retinopathy in patients with type 2 diabetes, severe gastrointestinal disease concerns, serious allergy, and suicidal behavior or thinking 1.
Pregnancy and contraception also matter. Tirzepatide may affect gastric emptying, which can affect how some oral medicines are absorbed. A clinician should review oral contraceptives, diabetes medicines, blood pressure medicines, and any medication with a narrow safety range before prescribing 10.
How much do tirzepatide pills cost?
Tirzepatide pill cost depends on the formulation, pharmacy, clinician program, follow-up model, shipping, and whether insurance is involved. A very low price can be a red flag if the seller skips prescriptions, screening, or pharmacy transparency.
At Chia, compounded tirzepatide tablets currently start at $249/mo, and compounded tirzepatide injections currently start at $299/mo. You can see current details on the tirzepatide product page. Chia also offers related protocols such as Weight + Energy, which includes NAD+ injection plus a choice of GLP-1, and Weight + Muscle, which includes Sermorelin injection plus a choice of GLP-1.
When comparing prices, ask what is included: clinician review, follow-up messaging, pharmacy dispensing, supplies if needed, shipping, and support if side effects happen. Our broader guide to weight loss drug costs explains how to compare GLP-1 programs without choosing an unsafe seller.
What should you check before buying tirzepatide online?
Before buying tirzepatide online, check whether the service acts like a medical clinic, not just a checkout page. A safe path includes screening, prescription review, pharmacy transparency, and follow-up.
- Does the service require a health questionnaire and prescription from a licensed clinician before medication is sent?
- Can you identify the pharmacy, and is it state-licensed?
- Does the seller avoid claims that compounded tirzepatide is equivalent to Zepbound or Mounjaro?
- Are instructions, labeling, storage details, and contact information included with the shipment?
- Is there a way to ask clinical questions after the medication arrives?
- Does the price seem realistic, or is it a deep-discount offer that feels too good to be true?
FDA warns consumers to be careful with sellers that do not require clinician screening, do not have a licensed clinician available for questions, claim a compounded drug is the same as an FDA-approved drug, or send medication in broken packaging, without instructions, or looking different from what was shown 2.
If a medication arrives warm, damaged, mislabeled, missing instructions, or different from what you expected, do not guess. Contact the pharmacy or telehealth platform that dispensed it. If you have symptoms such as severe abdominal pain, repeated vomiting, signs of dehydration, allergic reaction, or very low blood sugar, seek urgent medical care.
If you are still deciding between GLP-1 options, our guides on buying GLP-1 medication online, where to buy weight loss injections online, and oral GLP-1 options can help you compare routes and safety checks.
What do studies show about tirzepatide?
Tirzepatide evidence is strongest for subcutaneous injection in human randomized trials. These trials support why clinicians use the active ingredient, but they do not prove outcomes for compounded oral tablets.
In a randomized trial in people with type 2 diabetes, tirzepatide reduced appetite, energy intake, and fat mass 3. In SURMOUNT-1 body-composition analyses, researchers studied changes in body composition during weight reduction with tirzepatide in adults with obesity or overweight 7. These potential benefits must be weighed against gastrointestinal side effects and label warnings.
Tirzepatide has also been studied in obesity-related obstructive sleep apnea. In the SURMOUNT-OSA trials, tirzepatide was investigated for adults with obstructive sleep apnea and obesity 8. This does not mean every person with sleep apnea should use tirzepatide; it means the active ingredient has been studied in that population under trial conditions.
Long-term treatment questions are still important. SURMOUNT-MAINTAIN studied tirzepatide for maintenance of bodyweight reduction in people with obesity in a multicenter randomized trial 9. For any patient, the right plan should also include nutrition, movement, sleep, side-effect management, and follow-up.
3-min quiz
Start with a clinician-reviewed online visit
If you want to explore whether tirzepatide may be appropriate, Chia starts with an online intake reviewed by a licensed US provider. If prescribed, compounded medication is filled through a state-licensed 503A pharmacy and shipped to your door. A prescription is not guaranteed, and compounded drugs are not FDA-approved.
FAQ
Zepbound is a prescription injection. If a licensed clinician prescribes it, it is typically filled through a retail or mail-order pharmacy that carries FDA-approved medicines.
Yes, pharmacies can dispense tirzepatide when there is a valid prescription. FDA-approved tirzepatide products are injections. Some state-licensed compounding pharmacies may also prepare compounded tirzepatide when prescribed for an individual patient.
Tirzepatide is the active ingredient in Mounjaro and Zepbound. Mounjaro and Zepbound are brand-name FDA-approved injectable products. Compounded tirzepatide is not either brand product.
No. Zepbound is an FDA-approved tirzepatide injection. Compounded tirzepatide tablets are not Zepbound, are not FDA-approved, and do not have FDA-evaluated outcomes data.
No. Tirzepatide is prescription-only. A legitimate online or in-person path should include screening by a licensed clinician and pharmacy dispensing after a prescription is written.
No. Compounded tirzepatide tablets are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. They should be obtained only with a valid prescription from a licensed clinician and filled by an appropriate state-licensed pharmacy.
You need an evaluation by a licensed clinician. The clinician reviews your diagnosis, weight history, medications, lab needs, safety risks, and treatment goals, then decides whether a prescription is appropriate.
Tirzepatide activates GIP and GLP-1 receptors. Semaglutide is a GLP-1 receptor agonist. Both are prescription medicines, but they are different active ingredients with different labels, dosing forms, side-effect profiles, and eligibility factors.
References
- 1.U.S. Food and Drug Administration. FDA Approves New Medication for Chronic Weight Management. FDA News Release. 2023.
- 2.U.S. Food and Drug Administration. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. FDA Drug Safety Communication. 2025.
- 3.Heise T, DeVries JH, Urva S, et al. Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes. Diabetes Care. 2023.
- 4.Karagiannis T, Avgerinos I, Liakos A, et al. The effects of subcutaneous Tirzepatide on obesity and overweight: a systematic review and meta-regression analysis of randomized controlled trials. Diabetes, Obesity and Metabolism. 2023.
- 5.Dahl D, Onishi Y, Norwood P, et al. Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial. JAMA. 2022.
- 6.Jastreboff AM, le Roux CW, Stefanski A, et al. Tirzepatide for Obesity Treatment and Diabetes Prevention. The New England Journal of Medicine. 2025.
- 7.Look M, Dunn JP, Kushner RF, et al. Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight. Diabetes, Obesity and Metabolism. 2025.
- 8.Malhotra A, Grunstein RR, Fietze I, et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. The New England Journal of Medicine. 2024.
- 9.Horn DB, Aronne LJ, Wharton S, et al. Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial. Lancet. 2026.
- 10.Collins L, Costello RA. Tirzepatide. StatPearls. 2025.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if tirzepatide is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
